July 19, 2023
This study is for patients who have untreated, early-stage HER2-positive breast cancer
July 19, 2023
This study is for patients with solid tumors that are progressing after treatment with taxane therapies
March 23, 2023
Hospitals and cancer centers nationwide are opening ComboMATCH on a rolling basis over the next few months
January 5, 2023
This study is for patients who have aggressive, high-grade tumors that put them at higher risk of recurrence after treatment